Michele Solis is a freelance science writer based in Seattle, Washington
As obesity levels rise, pharmacists are finding they need new tools to ensure they adequately tailor the amount of medicine patients receive.
First described 200 years ago, Parkinson’s disease remains without a cure. After many failed clinical trials, researchers are getting back to basics to try to gain a better understanding of the challenges, and a new generation of treatment ideas are now in clinical trials, some of which aim to stall progression of the disease.
Some researchers argue that slowing the rate of biological ageing could be the best way to delay development of chronic diseases, such as cardiovascular disease, cancer and arthritis.
Autism: in search of new drug targetsSubscription
Heroin abuse: breaking the cycleSubscription